|
ANAGNOSTICS BIOANALYSIS GMBH
|
| On this site you find detailed information about
companies and institutions active in the Biotechnology (Biotech), Medical Technology (Medtech)
or Pharmaceutical (Pharma) industries, such as Anagnostics Bioanalysis GmbH. The Database informs you
about the product pipeline of a company, about financing rounds, investors, the technology
platform used etc. You can click on the company name below to see more detailed information. |
Anagnostics specializes in developing systems and tests for research and clinical in-vitro-diagnostics. Our aim is to provide solutions for unmet needs especially in protein assays (affinity measurements), DNA assays, mutation detection, (compact sequencing, adjunct to deep sequencing for DNA prep) and routine diagnostics such as drugs of abuse testing or infectious diseases.
Our products contribute to a better living by boosting life sciences and improving health care and therapeutic concepts.
Anagnostics' vision is to establish hybcell technology, a breakthrough development in microarray technology, in pharamaceutical research and clinical diagnostics.
Located in Linz, Austria, we started our developments in 2005. Our team comprises of specialists in molecular diagnostics, mechatronics and software engineering. |